GSK, SK Bioscience to test COVID-19 vaccine against AstraZeneca shot | Inquirer News

GSK, SK Bioscience to test COVID-19 vaccine against AstraZeneca shot

/ 03:32 PM August 31, 2021
GSK

A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS FILE PHOTO

Britain’s GSK and South Korea’s SK Bioscience said on Tuesday the drugmakers have begun a late-stage trial of their COVID-19 vaccine candidate to assess immune response when compared with AstraZeneca’s approved shot.

The trial will enrol around 4,000 candidates globally and test SK’s COVID-19 vaccine candidate, GBP510, in combination with GSK’s vaccine booster following positive early-stage data this month.

ADVERTISEMENT

Results from the GSK-SK study are expected in the first half next year, and the vaccine will be supplied worldwide through the World Health Organization-led vaccine sharing program COVAX if approved, the companies said.

FEATURED STORIES

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: AstraZeneca, COVID-19 Vaccines, GSK, Health, SK Bioscience, South korea
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.



© Copyright 1997-2023 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.